leisure time -WSS

leisure time

author：leisure time 2025-08-12 06:44:07 - browse：86

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： 'Weather

hotspot

leisure time

WSS

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

HCA says smaller share of spending going to labor

One Duchenne patient's bittersweet hope for new treatment

'Weather

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

leisure time

leisure time

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Medical records are filled with copy

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

State Dept. review finds Biden bears some blame for Afghanistan failures

Women's World Cup brings attention to abuse in soccer

Psychedelics group wrestles with new pharma identity

Grail's uphill battle for Medicare to cover its cancer screening test

Heart attack and stroke risk calculators need revising

France's anti

focus

House GOP plan to stem drug shortages differs from Democrats’

Many immigrants are left out of maternal health programs

One Duchenne patient's bittersweet hope for new treatment

House GOP plan to stem drug shortages differs from Democrats’

Superbugs, antibiotic resistance get scrutiny in congress

Snowpack in the West is melting rapidly. Where will all that extra water go?

focus

hotspot

leisure time

hotspot